Can a 1 ml vial of Botropase (botulinum toxin) be diluted with 10 ml of sterile normal saline for injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Botropase 1 mL dilution

No — do not dilute a 1 mL vial of “Botropase” to 10 mL NS; Botropase (per the FDA-labeled product available) is not a human botulinum toxin for injection and is labeled “not for use in humans,” so it should not be injected or reconstituted for human use at all. 1

  • What the label says (highest priority for safety/morbidity/mortality):

    • Botropase (as labeled in the provided FDA source) carries explicit warnings: “Not for use in humans,” risk of serious systemic effects, and special precautions for exposure; this precludes any clinical dilution or injection into patients 1.
    • Contact/AE reporting information further indicates this labeled product pertains to veterinary use, not human medical administration 1.
  • If your intent is botulinum toxin for human injection:

    • Use an FDA-approved human botulinum toxin product and follow that product’s specific reconstitution instructions (e.g., preserved or preservative-free saline volumes, unit equivalence), because dilution affects spread and adverse-effect risk; higher volumes increase diffusion area, which can impact functional outcomes and complications 2. Comparative studies in aesthetics suggest a range of dilutions can be effective, but product-specific guidance prevails to optimize safety and dosing accuracy 3.
    • Avoid ad hoc substitutions (e.g., veterinary-labeled products) to prevent severe morbidity and medicolegal risk.
  • Pitfalls/caveats to avoid:

    • Do not assume “Botropase” equals a standard human onabotulinumtoxinA vial; brand names vary by market and some are not human-use products. Verify the exact product label before reconstitution or injection 1.
    • Do not modify dilution beyond the approved human product’s instructions when treating conditions where toxin spread could worsen outcomes (ptosis, dysphagia, weakness) 2, 3.
  • If botulism treatment was the intent (antitoxin, not toxin):

    • Use botulinum antitoxin (BAT) per CDC guidance; dosing and administration follow CDC/FDA instructions for antitoxin, not “Botropase.” This is a different drug class entirely and time-sensitive for mortality reduction 4.

References

Research

Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007

Guideline

clinical guidelines for diagnosis and treatment of botulism, 2021.

MMWR Recommendations and Reports, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.